Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

TTSE:6090
559.00
JPY
-1.00
(-0.18%)
3.33BMarket Cap
Feb 18Next Earn

Total Valuation

JPY

As of June 30, 2026, Human Metabolome Technologies, Inc. carries a market capitalization of 3.33B, placing it among publicly traded companies globally. Its enterprise value stands at 1.99B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.33B
Enterprise Value1.99B

Important Dates

Human Metabolome Technologies, Inc.'s next confirmed earnings release is scheduled for February 18, 2027.

Earnings Date2/18/2027

Share Statistics

As of June 30, 2026, Human Metabolome Technologies, Inc. has 5.42M shares outstanding.

Shares Outstanding5.42M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio1.82
P/TBV Ratio1.85

Financial Position

As of June 30, 2026, Human Metabolome Technologies, Inc. maintains a current ratio of 4.03, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities.

Current Ratio4.03
Quick Ratio3.29
Debt / Equity5.68

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count62.75

Stock Price Statistics

JPY

As of the close on November 17, 2026, Human Metabolome Technologies, Inc.'s stock has declined approximately 13.60% over the past 52 weeks. The 50-day moving average sits at 597.18, while the 200-day moving average is 642.88.

52-Week Price Change-13.60%
50-Day Moving Average597.18
200-Day Moving Average642.88

Balance Sheet

JPY

As of June 30, 2026, Human Metabolome Technologies, Inc. holds 1.44B in cash and equivalents against 103.88M in total debt, resulting in a net debt position of -1.34B. Total book value stands at 1.83B, with working capital of 1.33B providing operational flexibility.

Cash & Cash Equivalents1.44B
Total Debt103.88M
Net Debt-1.34B
Equity (Book Value)1.83B
Book Value Per Share337.45
Working Capital1.33B